Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets
Cash	$ 3,305,281	$ 6,611,928
Accounts receivable, net of allowance for bad debt of $80,029 and $60,012	1,368,371	1,285,165
Royalty receivable	49,344	50,250
Inventory, net of allowance for obsolescence of $93,944 and $43,650	862,692	746,519
Prepaid other - related party	50,970	0
Prepaid and other assets	472,568	161,902
Total current assets	6,109,226	8,855,764
Long-term assets
Property, plant and equipment, net of accumulated depreciation of $91,424 and $60,694	227,002	204,953
Right of use assets - operating leases	527,371	585,251
Intangible assets, net of accumulated amortization of $698,079 and $603,580	3,226,696	1,471,194
Total long-term assets	3,981,069	2,261,398
Total assets	10,090,295	11,117,162
Current liabilities
Accounts payable	139,795	337,504
Accounts payable - related party	752,322	68,668
Accrued royalties and expenses	861,792	528,060
Accrued bonus and commissions	1,519,736	1,588,056
Operating lease liability - current	122,750	117,533
Short-term debt	190,433	0
Accrued interest	1,101	0
Total current liabilities	3,587,929	2,639,821
Long-term liabilities
Operating lease liability - long term	419,054	481,384
Convertible notes payable - related party	0	1,500,000
Long-term debt	392,567	0
Accrued interest - related party	0	103,557
Other long-term liabilities	77,092	0
Total long-term liabilities	888,713	2,084,941
Total liabilities	4,476,642	4,724,762
Shareholders' equity
Series F Convertible Preferred Stock: $10 par value, 1,200,000 shares authorized; none issued and outstanding as of June 30, 2020 and 1,136,815 issued and outstanding as of December 31, 2019	0	11,368,150
Common Stock: $0.001 par value, 20,000,000 shares authorized; 6,203,402 issued and outstanding as of June 30, 2020 and 3,571,001 issued and outstanding as of December 31, 2019	6,203	3,571
Additional paid-in capital	11,475,511	(2,081,829)
Accumulated deficit	(5,638,523)	(2,675,802)
Total Sanara MedTech shareholders' equity	5,843,191	6,614,090
Equity attributable to noncontrolling interest	(229,538)	(221,690)
Total shareholders' equity	5,613,653	6,392,400
Total liabilities and shareholders' equity	$ 10,090,295	$ 11,117,162